Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas - PubMed

Affiliations

• PMID: 16886971
• DOI: 10.1111/j.1365-2265.2006.02562.x

Practice Guideline

Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

Felipe F Casanueva et al. Clin Endocrinol (Oxf). 2006 Aug.

Abstract

In June 2005, an ad hoc Expert Committee formed by the Pituitary Society convened during the 9th International Pituitary Congress in San Diego, California. Members of this committee consisted of invited international experts in the field, and included endocrinologists and neurosurgeons with recognized expertise in the management of prolactinomas. Discussions were held that included all interested participants to the Congress and resulted in formulation of these guidelines, which represent the current recommendations on the diagnosis and management of prolactinomas based upon comprehensive analysis and synthesis of all available data.

Similar articles

• The management of hyperprolactinaemia.

  Jones TH. Jones TH. Br J Hosp Med. 1995 Apr 19-May 2;53(8):374-8. Br J Hosp Med. 1995. PMID: 7599897 Review.

• [Prolactinoma].

  Krysiak R, Okopień B, Marek B, Szkróbka W. Krysiak R, et al. Przegl Lek. 2009;66(4):198-205. Przegl Lek. 2009. PMID: 19708510 Review. Polish.

• [Management of prolactinomas during pregnancy].

  Chen W, Bian X, Gai M, Zhang Y. Chen W, et al. Zhonghua Fu Chan Ke Za Zhi. 2002 Jun 18;37(6):335-7. Zhonghua Fu Chan Ke Za Zhi. 2002. PMID: 12126566 Chinese.

• [Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia].

  Halperin Rabinovich I, Cámara Gómez R, García Mouriz M, Ollero García-Agulló D; Grupo de Trabajo de Neuroendocrinología de la SEEN. Halperin Rabinovich I, et al. Endocrinol Nutr. 2013 Jun-Jul;60(6):308-19. doi: 10.1016/j.endonu.2012.11.005. Epub 2013 Mar 9. Endocrinol Nutr. 2013. PMID: 23477758 Spanish.

• Hyperprolactinemia and prolactinomas.

  Mancini T, Casanueva FF, Giustina A. Mancini T, et al. Endocrinol Metab Clin North Am. 2008 Mar;37(1):67-99, viii. doi: 10.1016/j.ecl.2007.10.013. Endocrinol Metab Clin North Am. 2008. PMID: 18226731 Review.

Cited by

• Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth?

  Alkabbani AG, Mon SY, Hatipoglu B, Kennedy L, Faiman C, Weil RJ, Hamrahian AH. Alkabbani AG, et al. Pituitary. 2014 Apr;17(2):97-102. doi: 10.1007/s11102-013-0473-5. Pituitary. 2014. PMID: 23468127

• Pituitary tumors in MEN1: do not be misled by borderline elevated prolactin levels.

  Livshits A, Kravarusic J, Chuang E, Molitch ME. Livshits A, et al. Pituitary. 2016 Dec;19(6):601-604. doi: 10.1007/s11102-016-0752-z. Pituitary. 2016. PMID: 27600151

• Prolactinomas in adolescent and elderly patients-A comparative long-term analysis.

  Andereggen L, Tortora A, Schubert GA, Musahl C, Frey J, Luedi MM, Mariani L, Beck J, Christ E. Andereggen L, et al. Front Surg. 2023 Feb 6;10:967407. doi: 10.3389/fsurg.2023.967407. eCollection 2023. Front Surg. 2023. PMID: 36814862 Free PMC article.

• Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.

  Cooper O, Mamelak A, Bannykh S, Carmichael J, Bonert V, Lim S, Cook-Wiens G, Ben-Shlomo A. Cooper O, et al. Endocrine. 2014 Jun;46(2):318-27. doi: 10.1007/s12020-013-0093-x. Epub 2013 Nov 28. Endocrine. 2014. PMID: 24287797 Free PMC article. Clinical Trial.

• Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status.

  Pivonello R, De Martino MC, Auriemma RS, Alviggi C, Grasso LF, Cozzolino A, De Leo M, De Placido G, Colao A, Lombardi G. Pivonello R, et al. J Endocrinol Invest. 2014 Feb;37(2):99-112. doi: 10.1007/s40618-013-0019-8. Epub 2014 Jan 16. J Endocrinol Invest. 2014. PMID: 24497208 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information